Onodera K, Watanabe T
Department of Pharmacology, Tohoku University School of Dentistry, Sendai, Japan.
Nihon Shinkei Seishin Yakurigaku Zasshi. 1995 Apr;15(2):87-102.
The discovery of the presynaptic histamine H3 receptors confirmed the idea that histamine is a neurotransmitter in the mammalian brain. The H3 receptors (autoreceptors) regulate the release and synthesis of histamine. The H3 receptors also modulate the other neurotransmitters (heteroreceptors). Subclasses of H3 antagonist binding sites were found in the brain (H3A and H3B). The regulation of noradrenaline release is reported to be mediated by H3A rather than H3B. The H3 binding site belongs to the class of receptors coupled to G-proteins. Besides the molecular data, this review focuses on the functional roles of H3 receptors in the brain and discusses the possible use of H3 ligands for neurobehavioral disorders. The pharmacological data of H3 ligands may provide clinical candidates for CNS disorders in which histamine plays important roles in mental and behavioral functions. Especially, H3 antagonists may be useful for CNS disorders such as narcolepsy, dementia, epilepsy, and obesity, while H3 agonists may provide for anxiety, insomnia, migraine. However, these suggestions are still preliminary and further clinical research is needed, although potent and safe novel H3 ligands are being developed.
突触前组胺H3受体的发现证实了组胺是哺乳动物大脑中神经递质的观点。H3受体(自身受体)调节组胺的释放和合成。H3受体还可调节其他神经递质(异源受体)。在大脑中发现了H3拮抗剂结合位点的亚类(H3A和H3B)。据报道,去甲肾上腺素释放的调节由H3A而非H3B介导。H3结合位点属于与G蛋白偶联的受体类别。除了分子数据外,本综述重点关注H3受体在大脑中的功能作用,并讨论H3配体在神经行为障碍中的可能用途。H3配体的药理学数据可能为组胺在精神和行为功能中起重要作用的中枢神经系统疾病提供临床候选药物。特别是,H3拮抗剂可能对发作性睡病、痴呆、癫痫和肥胖等中枢神经系统疾病有用,而H3激动剂可能用于治疗焦虑、失眠和偏头痛。然而,这些建议仍属初步,尽管正在开发强效且安全的新型H3配体,但仍需要进一步的临床研究。